Investors' attention in Europe today turns once again to fashion companies (as a reminder, Hermès (RMS.FR) boasted its better-than-expected results yesterday. Kering (KER.FR), which is one of the largest fashion conglomerates, bringing together brands such as Gucci, Yves Saint Laurent and Bottega Venetta, is losing nearly 3.5% in early session trading, as the company reported significantly lower-than-expected quarterly results, which once again dented (after LVMH's results) opinion of continued consumer demand in the fashion market.
Key details of the report:
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appRevenue is down 13% year-on-year, primarily due to lower sales in stores and online channels. An additional aggravating factor is foreign exchange rates, which weakened results by 6% y/y. Source: Kering
The performance of Gucci, the brand that accounts for the largest share of the company's overall revenue structure, shows a continued decline in revenue on a quarterly basis. Source: Kering
The company's results (put them against expectations):
Overall, the company is posting worse-than-expected results in most of the key comparative measures for the company. Management said during a conference call that Ebit margins in 2023 for the Gucci brand are likely to decline. Source: Bloomberg Finance L.P.
Analysts' conclusions and comments:
- For the Kering conglomerate as a whole, the key brand is Gucci
- The brand was expected to experience a thaw this year, due to the change of artistic director to Sabato de Sarno
- However, due to weaker sales and an unfavorable macro environment, the impact of the brand changes may be seen with a delay
- Analysts at RBC Capital Markets point out that despite the weaker results, the company's current valuation appears to be discounting the news
- A decline in the company's comparable sales, along with a negative currency factor, could reduce the adjusted EBIT margin to 25%, according to Bloomberg Intelligence
Chart:
The company's shares are losing more than 25% on a quarterly basis and are currently trading below the €400 per share zone (levels not seen since March 2020. Source: xStation 5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.